REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 105 filers reported holding REVANCE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $255,212 | -79.8% | 14,210 | -67.0% | 0.00% | – |
Q2 2023 | $1,265,399 | +105.1% | 43,077 | +122.2% | 0.00% | – |
Q2 2021 | $617,000 | -11.5% | 19,385 | -22.9% | 0.00% | – |
Q1 2021 | $697,000 | -45.9% | 25,153 | -43.5% | 0.00% | -100.0% |
Q4 2020 | $1,289,000 | -33.8% | 44,534 | -41.7% | 0.00% | -50.0% |
Q3 2020 | $1,948,000 | +205.8% | 76,404 | +204.2% | 0.00% | +100.0% |
Q2 2020 | $637,000 | +128.3% | 25,118 | +23.0% | 0.00% | – |
Q1 2020 | $279,000 | -14.7% | 20,414 | +1.2% | 0.00% | – |
Q4 2019 | $327,000 | +151.5% | 20,168 | +101.2% | 0.00% | – |
Q3 2019 | $130,000 | -3.0% | 10,026 | -2.7% | 0.00% | – |
Q2 2019 | $134,000 | +162.7% | 10,301 | +217.7% | 0.00% | – |
Q1 2019 | $51,000 | -26.1% | 3,242 | -6.4% | 0.00% | – |
Q4 2018 | $69,000 | -14.8% | 3,465 | +7.4% | 0.00% | – |
Q3 2018 | $81,000 | +1250.0% | 3,227 | +1285.0% | 0.00% | – |
Q2 2018 | $6,000 | +200.0% | 233 | +219.2% | 0.00% | – |
Q4 2015 | $2,000 | -66.7% | 73 | -57.1% | 0.00% | – |
Q2 2014 | $6,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |